Interaction of OKL38 and p53 in regulating mitochondrial structure and function

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Hu, Jing ^a   Yao, Hongjie ^a,b   Gan, Fei ^a   Tokarski, Anthony ^a   Wang, Yanming ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; MEMBRANE PROTEIN; PROTEIN OKL38; PROTEIN P53; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; CELL STRUCTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRION; MORPHOLOGY; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION;

APOPTOSIS; BINDING SITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CYTOCHROMES C; DNA DAMAGE; GENETIC VARIATION; GREEN FLUORESCENT PROTEINS; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; PROTEIN BINDING; PROTEINS; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84865097949     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043362     Document Type: Article

References (39)

1. Vogelstein B, Lane D, Levine AJ, (2000) Surfing the p53 network. Nature 408: 307-310.
2. Riley T, Sontag E, Chen P, Levine A, (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412.
3. Hu W, Feng Z, Teresky AK, Levine AJ, (2007) p53 regulates maternal reproduction through LIF. Nature 450: 721-724.
4. Maiuri MC, Malik SA, Morselli E, Kepp O, Criollo A, et al. (2009) Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle 8: 1571-1576.
5. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
6. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, et al. (1994) Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 9: 1791-1798.
7. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, et al. (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058.
8. An W, Kim J, Roeder RG, (2004) Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 117: 735-748.
9. Brooks CL, Gu W, (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-171.
10. Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, et al. (2007) p53 is regulated by the lysine demethylase LSD1. Nature 449: 105-108.
11. Laptenko O, Prives C, (2006) Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 13: 951-961.
12. Li P, Yao H, Zhang Z, Li M, Luo Y, et al. (2008) Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol Cell Biol 28: 4745-4758.
13. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, et al. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303: 1010-1014.
14. Leu JI, Dumont P, Hafey M, Murphy ME, George DL, (2004) Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 6: 443-450.
15. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, et al. (2003) p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11: 577-590.
16. Green DR, Kroemer G, (2009) Cytoplasmic functions of the tumour suppressor p53. Nature 458: 1127-1130.
17. Nunnari J, Suomalainen A, (2012) Mitochondria: in sickness and in health. Cell 148: 1145-1159.
18. Wang C, Youle RJ, (2009) The role of mitochondria in apoptosis*. Annu Rev Genet 43: 95-118.
19. Youle RJ, Karbowski M, (2005) Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol 6: 657-663.
20. Hu W, Feng Z, Ma L, Wagner J, Rice JJ, et al. (2007) A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells. Cancer Res 67: 2757-2765.
21. Han MK, Song EK, Guo Y, Ou X, Mantel C, et al. (2008) SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2: 241-251.
22. Dumont P, Leu JI, Della Pietra AC, 3rd, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33: 357-365.
23. Yao H, Li P, Venters BJ, Zheng S, Thompson PR, et al. (2008) Histone Arg Modifications and p53 Regulate the Expression of OKL38, a Mediator of Apoptosis. J Biol Chem 283: 20060-20068.
24. Romanoski CE, Che N, Yin F, Mai N, Pouldar D, et al. (2011) Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1. Circ Res 109: e27-41.
25. Li R, Chen W, Yanes R, Lee S, Berliner JA, (2007) OKL38 is an oxidative stress response gene stimulated by oxidized phospholipids. J Lipid Res 48: 709-715.
26. Huynh H, Ng CY, Ong CK, Lim KB, Chan TW, (2001) Cloning and characterization of a novel pregnancy-induced growth inhibitor in mammary gland. Endocrinology 142: 3607-3615.
27. Wang T, Xia D, Li N, Wang C, Chen T, et al. (2005) Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis. J Biol Chem 280: 4374-4382.
28. Ong CK, Leong C, Tan PH, Van T, Huynh H, (2007) The role of 5′ untranslated region in translational suppression of OKL38 mRNA in hepatocellular carcinoma. Oncogene 26: 1155-1165.
29. Ong CK, Ng CY, Leong C, Ng CP, Foo KT, et al. (2004) Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis. J Biol Chem 279: 743-754.
30. Kitayner M, Rozenberg H, Kessler N, Rabinovich D, Shaulov L, et al. (2006) Structural basis of DNA recognition by p53 tetramers. Mol Cell 22: 741-753.
31. Wakabayashi T, (2002) Megamitochondria formation- physiology and pathology. J Cell Mol Med 6: 497-538.
32. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X, (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490.
33. Parone PA, James DI, Da Cruz S, Mattenberger Y, Donze O, et al. (2006) Inhibiting the mitochondrial fission machinery does not prevent Bax/Bak-dependent apoptosis. Mol Cell Biol 26: 7397-7408.
34. Brooks CL, Gu W, (2004) Dynamics in the p53-Mdm2 ubiquitination pathway. Cell Cycle 3: 895-899.
35. Shieh SY, Ikeda M, Taya Y, Prives C, (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334.
36. Beckman G, Birgander R, Sjalander A, Saha N, Holmberg PA, et al. (1994) Is p53 polymorphism maintained by natural selection? Hum Hered 44: 266-270.
37. Murphy ME, Leu JI, George DL, (2004) p53 moves to mitochondria: a turn on the path to apoptosis. Cell Cycle 3: 836-839.
38. Jin Y, Wang Y, Johansen J, Johansen KM, (2000) JIL-1, a chromosomal kinase implicated in regulation of chromatin structure, associates with the male specific lethal (MSL) dosage compensation complex. J Cell Biol 149: 1005-1010.
39. Li S, Lei L, Somerville CR, Gu Y, (2012) Cellulose synthase interactive protein 1 (CSI1) links microtubules and cellulose synthase complexes. Proc Natl Acad Sci U S A 109: 185-190.